Product Reports Resources Pricing Login Book a demo

GRAIL

Biotech & Life Sciences · Menlo Park, United States · Founded 2016

Developing blood tests for early cancer detection high-intensity sequencing, population-scale clinical trials, and state of the art Computer Science and Data Science

Valuation $8.00B
Revenue $147M

Investors

19 investors on GRAIL's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 1 investor entered at this stage
Series B+ 12 investors entered at this stage
Sequoia
Genuity Science
6 Dimensions Capital
Hillhouse Capital
China Merchant Securities International
HuangPu River Capital
CPP Investments
Ally Bridge Group
Industrial and Commercial Bank of China
Blue Pool Capital
Johnson & Johnson
CRF Investment

Global footprint

Where GRAIL has talent and traffic

Workforce by country
6 countries with
team presence
🇺🇸 United States94.7%
🇬🇧 United Kingdom4.8%
🇸🇪 Sweden0.1%
🇭🇰 Hong Kong0.1%
🇰🇷 South Korea0.1%
Top 5 of 6 shown
Web traffic by country
63K monthly visits
across markets
🇺🇸 United States59.5%
🇬🇧 United Kingdom5.6%
🇨🇦 Canada5.2%
🇸🇬 Singapore4.3%
🇮🇳 India4%
Top 5 markets shown

Talent graph

The shape of GRAIL's talent

Dealroom maps GRAIL's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

22 standout operatorsDealroom-flagged across the org
41 AI specialistsincl. 14 core researchers
1,121 employees mappedperson by person
DimensionScore
AI Talentlive Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock GRAIL's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$83M patent portfolio · 181 active families

Estimated portfolio value
$83M
1.0% of market cap · 28.7× smaller than top peer Illumina ($2.4B)
181 active patent families
Where GRAIL innovates BioinformaticsBiological organismCancer classificationCellComputational biology

Where GRAIL concentrates vs peers

Each axis is a top-10 topic across GRAIL and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about GRAIL

An AI-synthesized read of the highest-engagement posts about GRAIL on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See GRAIL on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.